about
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countriesImmune response and immunopathology during toxoplasmosisMolecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interfaceToxoplasmosis in Iran: A guide for general physicians working in the Iranian health network setting: A systematic reviewImmunity to Infections after Haploidentical Hematopoietic Stem Cell TransplantationLong-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic InfectionsCongenital toxoplasmosis: Clinical features, outcomes, treatment, and preventionParasites or cohabitants: cruel omnipresent usurpers or creative "éminences grises"?TgATAT-Mediated α-Tubulin Acetylation Is Required for Division of the Protozoan Parasite Toxoplasma gondiiVaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routesToxoplasmosis in immunocompromized patients.A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii.Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepaticaCardiac involvement with parasitic infections.IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in NewbornsCorrelation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosisMolecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.Importance of nonenteric protozoan infections in immunocompromised people.Epidemiology of and diagnostic strategies for toxoplasmosisSeroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan.Canonical histone H2Ba and H2A.X dimerize in an opposite genomic localization to H2A.Z/H2B.Z dimers in Toxoplasma gondii.Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study.Toxoplasmosis: a global threat.Conjugated Linoleic Acid Stimulates Apoptosis in RH and Tehran Strains of Toxoplasma gondii, in VitroCerebral toxoplasmosis in a diffuse large B cell lymphoma patient.Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemia.Toxoplasma gondii Infection and Mixed Anxiety and Depressive Disorder: A Case-Control Seroprevalence Study in Durango, MexicoAtypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency.Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention.Post-prophylaxis Toxoplasma chorioretinitis following donor-recipient mismatched liver transplantation.Immunity Status of Blood Donors Regarding Toxoplasma gondii Infection in a Low-Income District of Abidjan, Côte d'Ivoire, West Africa.Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation.Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR.Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients.Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.Neurological complications of transplantation.Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
P2860
Q21090649-F20ABB2A-8F67-45F2-83E0-B8DDFA6959C1Q24612341-0FCBBA6C-D3F0-43D6-9C3C-1D07569D4EF6Q26863427-E277E089-F085-4972-922F-18D3DF4FA30BQ28066251-6874466F-EAA1-4D63-A9D5-071D0F34A17AQ28079606-1AD9ECF0-E1E3-4C6D-B484-2053C9352447Q28082315-AA619847-E0D1-44B3-8B80-69A24DCBEB1CQ28598012-421F71A8-68C9-4DA1-A1E4-E57484EDF8CDQ28742405-CC56D7F5-B3E3-40DA-8F07-CD06A7E1F33CQ28834427-6465B6EC-3999-496E-AAE9-8CECACEB798DQ30096805-7BD3A04F-02FC-4CFD-803D-3E38C81E2F0CQ30228246-F7014AD8-5F6F-4871-9A75-3DF1F2637741Q30527857-6A3407AA-136F-4397-8C38-07A22471C771Q33455478-54A29381-BFF0-4EB8-A449-43AD5F4CAD5DQ33825602-1234F89C-484E-47D9-A044-BC6538AD5083Q33847295-C7D4E5F9-204A-4570-A2D4-5BA4CFAA39B5Q33963599-D369FA68-88F1-4A61-9BE6-0FAD833BB98EQ34043437-AA03EA56-7F27-4187-A620-F906526D9818Q34189873-3810CC9B-10A4-4DE9-9736-72C7FA848F3EQ34267180-D79EE16B-84F2-42D6-A278-FE7630212D7BQ34469348-2125F662-037B-466A-8E79-96FB43A51D9EQ34623289-3AEED1FF-8E5E-4674-8AC6-819BC118A93BQ34979036-E2D02DE5-F56A-4B6A-BAE9-FA281DFC1AEBQ35114966-D76F90E2-D5DF-44E6-8000-2CFDFCCFBA52Q35183980-53B21007-96D8-4322-BD59-50A0FFCB88A3Q35908753-F507AD00-EE60-4EF3-B995-4FD1AF110ACAQ36779863-2492B187-5A0D-4AA2-A18B-A841BEC645E1Q36884505-9399A76C-2D25-46E0-AA89-70CA17A15B38Q36971662-821C5E2C-CCCE-4DE2-BF5E-60FDBDF8EFDBQ37036262-EF6211C5-5908-4E9B-B148-6C16CD0355DFQ37308053-635D0C4B-7D4D-4C10-8014-895D9F16C59EQ37316505-38DAF23B-A957-43E3-8170-138C4C961C67Q37342639-183C2BAE-B305-49AE-BEDD-106B7C1AFD3BQ37349223-AFD8C1E9-BA19-4470-B74A-8B4388E108E4Q37464884-6CFB24CE-CB29-4340-97F9-49C5796707F5Q37639143-1CE4C192-3BE7-4990-BA7A-B3BC6C560C9AQ37648730-41D07A29-0A5F-4696-88E7-300B67FA7679Q37712037-BEE5EDD4-8DC5-4B93-A9F9-B2384747933BQ37901973-21D9B6D6-B3A3-41AA-B82E-ED6A733A9EF0Q38056870-4636FCC1-59F8-4526-BEDC-8A8371F2A941Q38070926-F349DB47-4C58-46E6-9330-63BEA186F457
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of toxoplasmosis in transplant patients.
@en
Prevention of toxoplasmosis in transplant patients.
@nl
type
label
Prevention of toxoplasmosis in transplant patients.
@en
Prevention of toxoplasmosis in transplant patients.
@nl
prefLabel
Prevention of toxoplasmosis in transplant patients.
@en
Prevention of toxoplasmosis in transplant patients.
@nl
P2093
P1476
Prevention of toxoplasmosis in transplant patients.
@en
P2093
ESCMID Study Group on Clinical Parasitology
P304
P356
10.1111/J.1469-0691.2008.02091.X
P577
2008-12-01T00:00:00Z